Neurofibromatosis
2021 Neurofibromatosis Research Highlights
- Nf1 Mutation Drives Neuronal-Activity-Dependent Initiation of Optic Glioma
- New Investigator Award Recipients Bring New Ideas to the Neurofibromatosis Research Program for Fiscal Year 2020
- Cabozantinib for Neurofibromatosis Type 1-Related Plexiform Neurofibromas: A Phase 2 Trial
- Everolimus Therapy for NF1-Optic Gliomas in Children: A Clinical Trial
Last updated Thursday, May 26, 2022